{"transactions":[{"id":1265399,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2025-02-18T22:00:13.000Z","date":"2025-02-14","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date."}],"balance_after":100000,"derivative":{"exercise_price":0.6,"expiration_date":"2032-02-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-25-007199","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315225007199/ownership.xml","form_type":"4"}},{"id":1570875,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2024-03-20T01:49:45.000Z","date":"2024-03-17","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest and become exercisable in four equal installments, with 25% of such award vesting and becoming exercisable on each of September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025 provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date."}],"balance_after":70000,"derivative":{"exercise_price":6,"expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001493152-24-010572","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315224010572/ownership.xml","form_type":"4"}},{"id":1847219,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-06-23T00:17:33.000Z","date":"2023-06-16","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock (the \"Option\"), with such option vesting in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 16, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This amended report on Form 4 is being filed to correct the Transaction Date and Expiration Date of the Option, which were inadvertently misreported in the original Form 4 filed on June 21, 2023."}],"balance_after":40000,"derivative":{"exercise_price":7.31,"expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-022163","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223022163/ownership.xml","form_type":"4/A","original_submission_date":"2023-06-21"}},{"id":1848315,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2023-06-21T20:15:26.000Z","date":"2023-06-19","kind":"grant","planned":false,"acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 19, 2023."}],"balance_after":40000,"derivative":{"exercise_price":7.31,"expiration_date":"2023-06-18","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-23-022007","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315223022007/ownership.xml","form_type":"4"}},{"id":2215849,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2022-07-05T23:51:37.000Z","date":"2022-07-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with such option vesting in four equal quarterly installments over one year, with the first quarterly installment to vest on September 30, 2022 and each additional installment to vest quarterly thereafter, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of July 1, 2022."}],"balance_after":40000,"derivative":{"exercise_price":12.92,"expiration_date":"2029-07-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001493152-22-018603","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315222018603/ownership.xml","form_type":"4"}},{"id":2674644,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2021-06-10T20:05:22.000Z","date":"2021-06-09","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with one-quarter of such stock option vesting on June 30, 2021 and the remaining portion vesting pro rata in equal monthly installments beginning July 31, 2021 and on the last day of each month thereafter, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 9, 2021."}],"balance_after":100000,"derivative":{"exercise_price":5.28,"expiration_date":"2028-06-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-21-014017","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315221014017/ownership.xml","form_type":"4"}},{"id":3033725,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option (right to buy)","published_at":"2020-09-11T20:17:20.000Z","date":"2020-09-10","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock, with one-quarter of such stock option vesting on September 30, 2020 and the remaining portion vesting pro rata in equal monthly installments beginning October 31, 2020 and on the last day of each month thereafter, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of September 10, 2020."}],"balance_after":100000,"derivative":{"exercise_price":2.83,"expiration_date":"2027-09-09","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001493152-20-017640","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220017640/ownership.xml","form_type":"4"}},{"id":3056485,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2020-08-17T20:30:30.000Z","date":"2020-08-13","kind":"purchase","acquired":true,"shares":50000,"price":2.75,"value":137500.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were purchased in a private transaction from Ted Karkus, Chairman and Chief Executive Officer of the Issuer, pursuant to the terms of a Stock Purchase Agreement"}],"balance_after":273840,"source":{"system":"sec-edgar","filing":"0001493152-20-016097","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220016097/ownership.xml","form_type":"4"}},{"id":3093793,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2020-07-02T17:32:28.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":7878,"price":1.43,"value":11265.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees."}],"balance_after":223840,"source":{"system":"sec-edgar","filing":"0001493152-20-012453","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220012453/ownership.xml","form_type":"4"}},{"id":3187749,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2020-04-02T21:50:28.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":6068,"price":1.85,"value":11225.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees."}],"balance_after":215962,"source":{"system":"sec-edgar","filing":"0001493152-20-005725","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220005725/ownership.xml","form_type":"4"}},{"id":3193589,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2020-03-27T23:17:50.000Z","date":"2020-03-26","kind":"purchase","acquired":true,"shares":100000,"price":1.75,"value":175000.0,"ownership":{"direct":true},"balance_after":209894,"source":{"system":"sec-edgar","filing":"0001493152-20-004963","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220004963/ownership.xml","form_type":"4"}},{"id":3325024,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2020-01-04T02:05:44.000Z","date":"2020-01-01","kind":"grant","acquired":true,"shares":5564,"price":2.02,"value":11239.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees."}],"balance_after":109894,"source":{"system":"sec-edgar","filing":"0001493152-20-000170","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315220000170/ownership.xml","form_type":"4"}},{"id":3399605,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2019-10-03T22:44:31.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":5740,"price":1.96,"value":11250.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued under the 2010 Directors' Equity Compensation Plan, as amended, pursuant to an election by the Reporting Person to receive shares of common stock of the Issuer in lieu of a cash payment for quarterly director fees."}],"balance_after":104330,"source":{"system":"sec-edgar","filing":"0001493152-19-015007","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315219015007/ownership.xml","form_type":"4"}},{"id":3436797,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2019-08-16T20:00:21.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":4727,"price":2.38,"value":11250.26,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for director fees payable to non-employee directors."}],"balance_after":98590,"source":{"system":"sec-edgar","filing":"0001493152-19-012854","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315219012854/ownership.xml","form_type":"4"}},{"id":3563349,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2019-04-04T22:07:03.000Z","date":"2019-04-03","kind":"grant","acquired":true,"shares":3571,"price":3.15,"value":11248.65,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for director fees payable to non-employee directors."}],"balance_after":93863,"source":{"system":"sec-edgar","filing":"0001493152-19-004917","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315219004917/ownership.xml","form_type":"4"}},{"id":3695865,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2019-01-16T00:40:56.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":3583,"price":3.14,"value":11250.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for director fees payable to non-employee directors."}],"balance_after":90292,"source":{"system":"sec-edgar","filing":"0001493152-19-000674","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315219000674/ownership.xml","form_type":"4"}},{"id":3803173,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2018-10-02T21:20:05.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":3737,"price":3.01,"value":11248.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for quarterly director fees payable to non-employee directors."}],"balance_after":86709,"source":{"system":"sec-edgar","filing":"0001493152-18-014009","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218014009/ownership.xml","form_type":"4"}},{"id":3863142,"issuer":{"id":8699,"kind":"organization","name":"ProPhase Labs, Inc."},"owners":[{"id":83141,"kind":"person","name":"GLECKEL LOUIS MD","position":1,"cik":"0001164762","reported_name":"GLECKEL LOUIS MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.0005","published_at":"2018-07-23T14:09:33.000Z","date":"2018-07-19","kind":"grant","acquired":true,"shares":3737,"price":3.01,"value":11248.37,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares of common stock were issued pursuant to the terms of the 2010 Directors' Equity Compensation Plan, as amended, for quarterly director fees payable to non-employee directors."}],"balance_after":82972,"source":{"system":"sec-edgar","filing":"0001493152-18-010342","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/868278/000149315218010342/ownership.xml","form_type":"4"}}]}